Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism autotaxin inhibitors(Ectonucleotide pyrophosphatase/phosphodiesterase 2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H50ClNO2S |
InChIKeyVBWFCMBRYMHQOO-UHFFFAOYSA-M |
CAS Registry1802053-21-9 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Melanoma | Preclinical | United States | 01 Sep 2015 |





